BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3435885)

  • 21. [Comparative medico-psychological study of patients with duodenal ulcer and patients with "functional digestive disease"].
    Pifano FN; de Posadas MA; Torbello J
    G E N; 1979; 33(1):5-13. PubMed ID: 120816
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment and relapse prophylaxis of duodenal ulcer with pirenzepine and cimetidine.
    Eichenberger PM; Giger M; Mattle W; Pelloni S; Müller-Lissner SA; Gonvers JJ; Birchler R; Blum AL
    Scand J Gastroenterol Suppl; 1982; 72():197-205. PubMed ID: 6753114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. H2 receptor antagonist or H. pylori eradication?
    Ahmed W; Qureshi H; Syed S; Alam E; Zuberi SJ
    J Pak Med Assoc; 1992 Apr; 42(4):81-2. PubMed ID: 1350800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ranitidine in the prevention of gastric and duodenal ulcer relapse.
    Alstead EM; Ryan FP; Holdsworth CD; Ashton MG; Moore M
    Gut; 1983 May; 24(5):418-20. PubMed ID: 6301956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of stressful life events in duodenal ulcer recurrence: a prospective study.
    Magni G; Borgherini G; Zennaro A; Muscara A; Di Mario F
    J Clin Psychol; 1994 Sep; 50(5):711-4. PubMed ID: 7806647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Life events, personality, and physical risk factors in recent-onset duodenal ulcer. A preliminary study.
    Levenstein S; Prantera C; Varvo V; Spinella S; Arcà M; Bassi O
    J Clin Gastroenterol; 1992 Apr; 14(3):203-10. PubMed ID: 1564296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maintenance treatment of recurrent duodenal ulceration with pirenzepine.
    Petrillo M; Bianchi Porro G
    Hepatogastroenterology; 1980 Oct; 27(5):369-71. PubMed ID: 7009360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of cigarette smoking on healing and relapse in duodenal ulcer disease.
    Korman MG; Hansky J; Eaves ER; Schmidt GT
    Gastroenterology; 1983 Oct; 85(4):871-4. PubMed ID: 6136450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of anxiety and personality in non-ulcer dyspepsia: a comparative study with duodenal ulcer.
    Alexander PJ; Tantry BV
    Indian J Gastroenterol; 1993 Jul; 12(3):86-8. PubMed ID: 8354535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Supportive antisecretory therapy in preventing duodenal ulcer recurrence].
    Sholomitskaia IA; Kapralov NV; Soroka NF
    Eksp Klin Gastroenterol; 2005; (5):28-33, 123. PubMed ID: 16518911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Refractory duodenal ulcer healing and relapse: comparison of omeprazole with Helicobacter pylori eradication.
    Avsar E; Kalayci C; Tözün N; Lawrence R; Kiziltas S; Gültekin O; Ulusoy NB
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):449-52. PubMed ID: 8804873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cost-effectiveness analysis of the eradication of Helicobacter pylori as treatment for duodenal ulcer].
    Fernández Muñoz J; López de Andrés A; Zapater Hernández P; Abad Santos F
    An Med Interna; 1998 Oct; 15(10):515-22. PubMed ID: 9844225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-inflammatory and carbonic anhydrase restoring actions of yam powder (Dioscorea spp) contribute to the prevention of cysteamine-induced duodenal ulcer in a rat model.
    Park JM; Kim YJ; Kim JS; Han YM; Kangwan N; Hahm KB; Kim TS; Kwon O; Kim EH
    Nutr Res; 2013 Aug; 33(8):677-85. PubMed ID: 23890358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relapse of duodenal ulcer: does it matter which drug is used in initial treatment?
    Miller JP; Faragher EB
    Br Med J (Clin Res Ed); 1986 Nov; 293(6555):1117-8. PubMed ID: 3094799
    [No Abstract]   [Full Text] [Related]  

  • 35. Psychosocial causes of duodenal ulcer.
    Tennant C
    Aust N Z J Psychiatry; 1988 Jun; 22(2):195-201. PubMed ID: 3041960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Esomeprazole in treating duodenal ulcer in various modes of anti-Helicobacter therapy].
    Maev IV; Kurilo AE; V'iuchnova ES; Shchekina MI
    Ter Arkh; 2003; 75(2):23-6. PubMed ID: 12685385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Personality characteristics of patients with different clinical forms of duodenal peptic ulcer].
    Podorozhnyĭ PG; Vdovichenko VI
    Vrach Delo; 1986 Aug; (8):77-8. PubMed ID: 3776168
    [No Abstract]   [Full Text] [Related]  

  • 38. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
    Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A
    Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Course of duodenal ulcer disease depending on personality type and effectiveness of differential psychotropic therapy].
    Beloborodova EI; Pisarenko IV; Dorokhova TA
    Ter Arkh; 2002; 74(8):60-4. PubMed ID: 12360600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short- and long-term studies of duodenal ulcer with sucralfate.
    Moshal MG; Spitaels JM; Khan F
    J Clin Gastroenterol; 1981; 3(Suppl 2):159-61. PubMed ID: 6895644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.